Literature DB >> 1521520

Living with acromegaly.

S Ezzat1.   

Abstract

Acromegaly is an unusual insidious but potentially serious chronic pituitary disorder. The delay in diagnosis results not only in unique somatic disfigurement but is also associated with significant mental and emotional dysfunction. This article reviews and describes some of these nonclassic and often overlooked features of acromegaly. Particular emphasis is placed on presenting the patients' perspectives of the condition. The author offers some suggestions on the care and counseling of the acromegalic patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521520

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Neurology of the pituitary gland.

Authors:  J R Anderson; N Antoun; N Burnet; K Chatterjee; O Edwards; J D Pickard; N Sarkies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

Review 2.  Treatment options in acromegaly. Benefits and costs.

Authors:  L M Weekes; K K Ho; J P Seale
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 3.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

4.  Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.

Authors:  Sang Ouk Chin; Choon Hee Chung; Yoon-Sok Chung; Byung-Joon Kim; Hee Young Kim; In-Ju Kim; Jung Guk Kim; Min-Seon Kim; Seong-Yeon Kim; Eun Jig Lee; Ki Young Lee; Sung-Woon Kim
Journal:  BMJ Open       Date:  2015-06-10       Impact factor: 2.692

5.  Acromegaly Quality of Life Questionnaire (AcroQoL).

Authors:  Xavier Badia; Susan M Webb; Luis Prieto; Nuria Lara
Journal:  Health Qual Life Outcomes       Date:  2004-02-27       Impact factor: 3.186

6.  Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.

Authors:  Sonia Cheng; Rany Al-Agha; Paula B Araujo; Omar Serri; Sylvia L Asa; Shereen Ezzat
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.